Myhibbin Suspension
Product Images NDC 24338-018

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Myhibbin (NDC 24338-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Bottle Label)

This is a description of Mycophenolate Mofetil Oral Suspension. It contains mycophenolate mofetil, methylparaben, and propylparaben. The recommended dosage should be reviewed in the prescribing information. It is essential to shake well before use and to store the suspension between 20°C to 25°C. The product should not be frozen and needs to be kept out of the reach of children. It is for oral use only and each patient should receive a Medication Guide. In case of contact with the skin, it should be washed thoroughly with soap and water. After opening, any unused portion should be discarded after 60 days.*

FDA Label Image

Carton Label (Carton Label)

This is a description of a medication called Myhibbin (Mycophenolate Mofetil Oral Suspension) with a strength of 200 mg/m and a raspberry flavor. The medication comes in a bottle of 175 mL and is recommended for oral use only. The text also mentions storage instructions, dosage guidelines, NDC number, and provides a note for pharmacists to dispense a Medication Guide to each patient. Additionally, there are instructions for opening the bottle and some safety information. For more details, visit myhibbin.com/medication-guide.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.